Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 3, 2025
Welcome, Future. Sistema endoscopico ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Germania, April 03, 2025 (GLOBE NEWSWIRE) -- Il team FUJIFILM Healthcare Europe è entusiasta di annunciare l’uscita in Europa di ELUXEO® 8000*, il nostro nuovo sistema endoscopico avanzato che include nuove capacità terapeutiche, gestione del …
Welcome, Future (Bem-vindo, futuro). Sistema de endoscopia ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Alemanha, April 03, 2025 (GLOBE NEWSWIRE) -- A equipa da FUJIFILM Healthcare Europe tem o prazer de anunciar o lançamento na Europa do ELUXEO® 8000*, o novo sistema de endoscopia avançada com novas capacidades terapêuticas, gestão do fluxo de …
Welcome, Future (Bienvenido, futuro). Sistema de endoscopia ELUXEO® 8000
GlobeNewswire
·
April 3, 2025
RATINGEN, Alemania, April 03, 2025 (GLOBE NEWSWIRE) -- Al equipo de FUJIFILM Healthcare Europe nos complace anunciar el lanzamiento de ELUXEO 8000, nuestro nuevo sistema de endoscopia avanzado con nuevas capacidades terapéuticas, gestión del flujo de …
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
GlobeNewswire
·
April 3, 2025
Press release LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the …
Welcome, Future. ELUXEO® 8000 Endoscopy System
GlobeNewswire
·
April 3, 2025
RATINGEN, Germany, April 03, 2025 (GLOBE NEWSWIRE) -- The FUJIFILM Healthcare Europe Team are excited to announce the European launch of ELUXEO® 8000*, our new advanced endoscopy system with new therapeutic capabilities, workflow management and improved …
Welcome, Future (Welkom, toekomst). ELUXEO® 8000 Endoscopy-systeem
GlobeNewswire
·
April 3, 2025
RATINGEN, Duitsland, April 03, 2025 (GLOBE NEWSWIRE) -- Het FUJIFILM Healthcare Europe-team kondigt met trots de Europese lancering aan van ELUXEO® 8000*, ons nieuwe geavanceerde endoscopiesysteem met nieuwe therapeutische mogelijkheden, workflowmanagement …
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
GlobeNewswire
·
April 3, 2025
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and …
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé
GlobeNewswire
·
April 3, 2025
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé Désignation accordée pour l’anémie hémolytique à anticorps chauds et la maladie …
Veteran Banker Joins Avextra’s Supervisory Board
GlobeNewswire
·
April 3, 2025
News Release Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board, bringing decades of experience in corporate finance, M…
FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt
GlobeNewswire
·
April 3, 2025
HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (im Folgenden kurz „FibroBiologics“), ein im klinischen Stadium tätiges Biotechnologieunternehmen mit über 240 erteilten und angemeldeten Patenten für die Entwicklung von …
FibroBiologics annonce des progrès scientifiques suite à la confirmation des résultats relatifs à la réparation de tissus cérébraux
GlobeNewswire
·
April 3, 2025
HOUSTON, 03 avr. 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq : FBLG), ou « FibroBiologics », une société de biotechnologie au stade clinique détenant plus de 240 brevets délivrés et en instance portant sur le développement de thérapies et de …
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
GlobeNewswire
·
April 3, 2025
ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary …